Skip to main content
. 2011 Mar 2;96(5):1516–1523. doi: 10.1210/jc.2010-2662

Table 4.

Characteristics of the study population stratified by the presence or absence of corticotropin or thyrotropin deficiency

Variable Corticotropin deficiency vs. sufficiency
Thyrotropin deficiency vs. sufficiency
Def Suff P value Def Suff P value
Number (n) 834 383 870 346
Age at diagnosis of pituitary disease (yr) 40.1 (22.3, 58.9) 43.2 (21.3, 60.7) NS 40.4 (21.9, 59.1) 41.4 (22.7, 60.5) NS
Age at diagnosis of GHD (yr) 46.8 (28.5, 63.7) 46.4 (27.9, 62.4) NS 46.9 (28.3, 63.7) 45.8 (27.9, 62.4) NS
Age at KIMS entry (yr) 48.8 (31.4, 65.7) 47.6 (29.6, 64.2) NS 49.1 (31.5, 66.0) 46.9 (29.1, 63.8) <0.05
Estimated GHD duration (yr) 0.7 (0.0, 6.9) 0.7 (0.0, 4.0) NS 0.7 (0.0, 7.1) 0.7 (0.0, 3.7) NS
Gender [females/males (%/%)] 429/405 (51/49) 212/171 (55/45) NS 461/409 (53/47) 180/166 (52/48) NS
IGF-I SDS −1.7 (−3.7, −0.1) −1.1 (−3.0, 0.2) <0.001 −1.8 (−3.7, −0.1) −1.1 (−2.7, 0.3) <0.001
History of fracture [n (%)] 200 (24) 80 (21) NS 200 (23) 79 (23) NS
LS sBMD (mg/cm2) 1028 (828, 1285) 1055 (885, 1295) <0.01 1032 (838, 1295) 1038 (869, 1285) NS
LS z score −0.8 (−2.2, 1.3) −0.3 (−1.8, 1.7) <0.01 −0.5 (−2.1, 1.5) −0.3 (−1.9, 1.3) NS
FN sBMD (mg/cm2) 871 (691, 1063) 883 (704, 1066) NS 878 (691, 1076) 878 (700, 1057) NS
FN z score −0.4 (−1.7, 1.1) 0 (−1.5, 1.2) <0.01 −0.3 (−1.7, 1.2) −0.1 (−1.6, 1.1) NS

Data are shown as number of patients, percentages, mean ± sd, or median (10th and 90th percentiles) as appropriate. Def, Deficient; NS, not significant; suff, sufficient.